Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bridgebio Pharma Inc
(NQ:
BBIO
)
29.28
-0.24 (-0.81%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bridgebio Pharma Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
July 17, 2023
Via
Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 17, 2023
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...
Via
Benzinga
Nasdaq Gains 100 Points; Guaranty Bancshares Posts Upbeat Results
July 17, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Monday. The Dow traded up 0.19% to 34,574.01 while the NASDAQ rose 0.71% to 14,214.50. The S&P...
Via
Benzinga
Why BridgeBio Pharma Stock Is Plunging Today
June 15, 2023
A cautionary note from JPMorgan is weighing on the biotech's shares today.
Via
The Motley Fool
BridgeBio Pharma: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About BridgeBio Pharma
April 13, 2023
Via
Benzinga
Why Are Telecom Stocks Down Today?
July 17, 2023
Telecom stocks aren't doing so how on Monday after several players in the space were hit by downgrades and lowered price targets from Citi.
Via
InvestorPlace
BridgeBio Launches 64% Higher, Pulling Alnylam And Ionis With It, On A 'Best-Case' In Heart Disease
July 17, 2023
The companies are working on treatments for a leading cause of heart failure.
Via
Investor's Business Daily
Why Is BridgeBio (BBIO) Stock Up 63% Today?
July 17, 2023
BridgeBio Pharma (BBIO) stock is climbing higher on Monday as investors react to results from a recent Phase 3 clinical trial.
Via
InvestorPlace
US Stocks Edge Higher; NY Empire State Manufacturing Index Falls In July
July 17, 2023
U.S. stocks traded slightly higher this morning, with the Dow Jones moving higher by around 20 points on Monday. Following the market opening Monday, the Dow traded up 0.06% to 34,529.57 while the...
Via
Benzinga
You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers
July 17, 2023
Big gains are afoot even as the markets prepare for a flat open.
Via
The Motley Fool
2 Best Growth Stocks to Buy in April
April 03, 2023
Takeover interest is spurring these two biotech stocks higher.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 17, 2023
Via
Benzinga
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket
July 17, 2023
Gainers
Via
Benzinga
BridgeBio Pharma Shares Are Shooting Higher Today - Here's Why
July 17, 2023
BridgeBio Pharma Inc (NASDAQ: BBIO) released results from ATTRibute-CM Phase 3 study of acoramidis in transthyretin
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 17, 2023
It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!
Via
InvestorPlace
Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 17, 2023
U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
2 Nasdaq Stocks That Could Soar This Week
July 16, 2023
BridgeBio Pharma and Roivant Sciences could make big moves this week.
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
July 14, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
July 12, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 11, 2023
Via
Benzinga
BioMarin Presents ~20% Upside Amid Voxzogo's Success and Slow Roctavian Uptake, Analyst Says
July 05, 2023
BMO Capital Markets has upgraded BioMarin Pharmaceutical Inc (NASDAQ: BMRN) to Outperform from Market Perform, and the price target remains at $102,
Via
Benzinga
2 Growth Stocks With Major Incoming Catalysts
June 27, 2023
Binary events slated for July could quickly send these biotech stocks through the roof.
Via
The Motley Fool
Second Quarter Outlook For Biotech Stocks
April 25, 2023
Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity.
Via
Talk Markets
Top 5 Best And Worst U.S. Industry ETFs In Q1 2023: AI and Bank Turmoil Shaped Stock Returns
March 31, 2023
The first quarter of 2023 was positive for the U.S. stock market as a whole, with the S&P 500 index faithfully tracked by the SPDR S&P 500 ETF Trust (ARCA: SPY), rising by 6%.
Via
Benzinga
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 19, 2023
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.
Via
Benzinga
Stocks Rise As Investors Bet On Bank Recovery
March 29, 2023
Stocks are swinging higher today, as bond yields retreat and Wall Street bets that the worst of the regional banking crisis is in the rearview mirror.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023
April 19, 2023
Via
Benzinga
Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today's Top Stories
March 27, 2023
Benzinga
Via
Benzinga
Rare Disease Player BridgeBio Pharma Draws Attention Of Big Pharma Companies, Gets Takeover Interest
March 27, 2023
BridgeBio Pharma Inc (NASDAQ: BBIO) is reportedly attracting takeover interest as some large pharmaceutical companies are studying a potential acquisition of the biotech firm.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.